USANA HEALTH SCIENCES, INC. Cost of Revenue
USANA HEALTH SCIENCES, INC. (USNA) reported Cost of Revenue of $48.34 million for the 3-month period ending 2026-07-04, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-13
- USANA HEALTH SCIENCES, INC. cost of goods and services sold for the quarter ending 2026-07-04 was $48.34M, a 3.68% decline year-over-year.
- USANA HEALTH SCIENCES, INC. cost of goods and services sold for the quarter ending 2026-04-04 was $59.44M, a 13.33% increase year-over-year.
- USANA HEALTH SCIENCES, INC. cost of goods and services sold for the quarter ending 2026-01-03 was $49.41M, a 28.16% increase year-over-year.
- USANA HEALTH SCIENCES, INC. cost of goods and services sold for the quarter ending 2025-09-27 was $48.81M, a 24.35% increase year-over-year.
- USANA HEALTH SCIENCES, INC. cost of goods and services sold for fiscal 2026 was $200.85M, a 24.59% increase from fiscal 2024.
- USANA HEALTH SCIENCES, INC. cost of goods and services sold for fiscal 2024 was $161.21M, a 8.76% decline from fiscal 2023.
- USANA HEALTH SCIENCES, INC. cost of goods and services sold for fiscal 2023 was $176.69M, a 8.87% decline from fiscal 2022.
- USANA HEALTH SCIENCES, INC. cost of goods and services sold for fiscal 2022 was $193.89M, a 11.02% decline from fiscal 2022.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-07-04 | $48.34M 10-Q · filed 2026-08-13 | $107.78M 10-Q · filed 2026-08-13 | $157.18M derived: sum of 3 quarters · filed 2026-08-13 | $206.00M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-04-04 | $59.44M 10-Q · filed 2026-05-12 | $108.84M derived: sum of 2 quarters · filed 2026-05-12 | $157.66M derived: sum of 3 quarters · filed 2026-05-12 | $207.84M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-01-03 | $49.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $98.22M derived: sum of 2 quarters · filed 2026-03-16 | $148.41M derived: sum of 3 quarters · filed 2026-08-13 | $200.85M 10-K · filed 2026-03-16 |
| 2025-09-27 | $48.81M 10-Q · filed 2025-11-05 | $99.00M derived: sum of 2 quarters · filed 2026-08-13 | $151.44M 10-Q · filed 2025-11-05 | $190.00M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-28 | $50.18M 10-Q · filed 2026-08-13 | $102.63M 10-Q · filed 2026-08-13 | $141.18M derived: sum of 3 quarters · filed 2026-08-13 | $180.44M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-29 | $52.45M 10-Q · filed 2026-05-12 | $91.00M derived: sum of 2 quarters · filed 2026-05-12 | $130.25M derived: sum of 3 quarters · filed 2026-05-12 | $170.59M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-28 | $38.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $77.81M derived: sum of 2 quarters · filed 2026-03-16 | $118.14M derived: sum of 3 quarters · filed 2026-03-16 | $161.21M 10-K · filed 2026-03-16 |
| 2024-09-28 | $39.26M 10-Q · filed 2025-11-05 | $79.59M derived: sum of 2 quarters · filed 2025-11-05 | $122.66M 10-Q · filed 2025-11-05 | $164.98M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-06-29 | $40.33M 10-Q · filed 2025-08-05 | $83.40M 10-Q · filed 2025-08-05 | $125.72M derived: sum of 3 quarters · filed 2026-03-16 | $168.25M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-03-30 | $43.07M 10-Q · filed 2025-05-06 | $85.39M derived: sum of 2 quarters · filed 2026-03-16 | $127.92M derived: sum of 3 quarters · filed 2026-03-16 | $171.24M derived: sum of 4 quarters · filed 2026-03-16 |
| 2023-12-30 | $42.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $84.85M derived: sum of 2 quarters · filed 2026-03-16 | $128.17M derived: sum of 3 quarters · filed 2026-03-16 | $176.69M 10-K · filed 2026-03-16 |
| 2023-09-30 | $42.53M 10-Q · filed 2024-11-05 | $85.86M derived: sum of 2 quarters · filed 2024-11-05 | $134.37M 10-Q · filed 2024-11-05 | $180.80M derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-07-01 | $43.33M 10-Q · filed 2024-08-06 | $91.84M 10-Q · filed 2024-08-06 | $138.28M derived: sum of 3 quarters · filed 2025-03-12 | $184.84M derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-04-01 | $48.52M 10-Q · filed 2024-05-07 | $94.95M derived: sum of 2 quarters · filed 2025-03-12 | $141.51M derived: sum of 3 quarters · filed 2025-03-12 | $191.03M derived: sum of 4 quarters · filed 2025-03-12 |
| 2022-12-31 | $46.43M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $92.99M derived: sum of 2 quarters · filed 2025-03-12 | $142.51M derived: sum of 3 quarters · filed 2025-03-12 | $193.89M 10-K · filed 2025-03-12 |
| 2022-10-01 | $46.56M 10-Q · filed 2023-11-07 | $96.08M derived: sum of 2 quarters · filed 2023-11-07 | $147.46M 10-Q · filed 2023-11-07 | $199.98M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-07-02 | $49.52M 10-Q · filed 2023-08-08 | $100.90M 10-Q · filed 2023-08-08 | $153.42M derived: sum of 3 quarters · filed 2024-02-27 | $204.13M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-04-02 | $51.38M 10-Q · filed 2023-05-09 | $103.90M derived: sum of 2 quarters · filed 2024-02-27 | $154.62M derived: sum of 3 quarters · filed 2024-02-27 | $211.63M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-01-01 | $52.52M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $103.23M derived: sum of 2 quarters · filed 2024-02-27 | $160.25M derived: sum of 3 quarters · filed 2024-02-27 | $217.90M 10-K · filed 2024-02-27 |
| 2021-10-02 | $50.72M 10-Q · filed 2022-11-08 | $107.73M derived: sum of 2 quarters · filed 2022-11-08 | $165.38M 10-Q · filed 2022-11-08 | $224.40M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-07-03 | $57.01M 10-Q · filed 2022-08-09 | $114.67M 10-Q · filed 2022-08-09 | $173.69M derived: sum of 3 quarters · filed 2023-02-28 | $230.04M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-04-03 | $57.65M 10-Q · filed 2022-05-11 | $116.67M derived: sum of 2 quarters · filed 2023-02-28 | $173.03M derived: sum of 3 quarters · filed 2023-02-28 | $220.70M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-01-02 | $59.02M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $115.38M derived: sum of 2 quarters · filed 2023-02-28 | $163.05M derived: sum of 3 quarters · filed 2023-02-28 | $209.11M 10-K · filed 2023-02-28 |
| 2020-09-26 | $56.36M 10-Q · filed 2021-11-10 | $104.03M derived: sum of 2 quarters · filed 2021-11-10 | $150.09M 10-Q · filed 2021-11-10 | $197.38M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-27 | $47.67M 10-Q · filed 2021-08-11 | $93.73M 10-Q · filed 2021-08-11 | $141.02M derived: sum of 3 quarters · filed 2022-03-01 | $188.84M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-28 | $46.06M 10-Q · filed 2021-05-11 | $93.35M derived: sum of 2 quarters · filed 2022-03-01 | $141.17M derived: sum of 3 quarters · filed 2022-03-01 | $187.66M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-28 | $47.29M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $95.11M derived: sum of 2 quarters · filed 2022-03-01 | $141.60M derived: sum of 3 quarters · filed 2022-03-01 | $187.50M 10-K · filed 2022-03-01 |
| 2019-09-28 | $47.82M 10-Q · filed 2020-11-03 | $94.31M derived: sum of 2 quarters · filed 2020-11-03 | $140.21M 10-Q · filed 2020-11-03 | $189.68M derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-06-29 | $46.49M 10-Q · filed 2020-08-04 | $92.39M 10-Q · filed 2020-08-04 | $141.86M derived: sum of 3 quarters · filed 2021-03-02 | $193.74M derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-03-30 | $45.90M 10-Q · filed 2020-05-05 | $95.37M derived: sum of 2 quarters · filed 2021-03-02 | $147.25M derived: sum of 3 quarters · filed 2021-03-02 | $197.24M derived: sum of 4 quarters · filed 2021-03-02 |
| 2018-12-29 | $49.47M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $101.34M derived: sum of 2 quarters · filed 2021-03-02 | $151.34M derived: sum of 3 quarters · filed 2021-03-02 | $200.71M 10-K · filed 2021-03-02 |
| 2018-09-29 | $51.88M 10-Q · filed 2019-11-05 | $101.87M derived: sum of 2 quarters · filed 2019-11-05 | $151.24M 10-Q · filed 2019-11-05 | $196.96M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $49.99M 10-Q · filed 2019-08-06 | $99.37M 10-Q · filed 2019-08-06 | $145.08M derived: sum of 3 quarters · filed 2020-02-25 | $192.21M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $49.38M 10-Q · filed 2019-05-07 | $95.09M derived: sum of 2 quarters · filed 2020-02-25 | $142.22M derived: sum of 3 quarters · filed 2020-02-25 | |
| 2017-12-30 | $45.71M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $92.85M derived: sum of 2 quarters · filed 2020-02-25 | $179.40M 10-K · filed 2020-02-25 | |
| 2017-09-30 | $47.13M 10-Q · filed 2018-11-07 | $133.69M 10-Q · filed 2018-11-07 | ||
| 2016-12-31 | $180.19M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |